ÂÜÀòÂÒÂ×

David Bingaman serves as Chief Development Officer at MERIT CRO since October 2024 and as President & Chief Executive Officer at PanOptica, Inc. from March 2023. Previously, David held the position of Chief Development Officer at Amydis, Inc. and served as Senior Advisor for Development & Innovation Strategy at Ora, Inc. where responsibilities included Clinical Operations, Regulatory Affairs, Preclinical, and CMC. Additional experience includes Vice President and Head of Global Clinical Development at Oculis S.A., and prior roles at PanOptica, Inc. and ALCON RESEARCH LTD. David holds a PhD in Ocular Angiogenesis from Indiana University–Purdue University Indianapolis and extensive training in veterinary medicine from multiple institutions, including a Doctor of Veterinary Medicine from Washington State University.